// App-Quantinova.ai

: Sporadic vs. MEN-associated pancreatic neuroendocrine tumors: multi-institutional clinicopathologic comparison

Researchers

Presenter

  • J. Bergquist

Principal Investigators

  • A. Li

  • N. Chatzizacharias

  • Z. Soonawalla

  • P. Athanasopoulos

  • P. Hansen

  • R. Parks

  • B. Lawrence

  • B. Visser

Medical Centers

  • University of Auckland, New Zealand.

  • Oxford University Hospital, United Kingdom

  • Providence Portland, United States

  • University of Edinburgh, Glasgow, United Kingdom

  • Surgery, Stanford University, United States

  • HPB Surgery, University of Cambridge and Addenbrooke's Hospital, United Kingdom

  • University College London, Royal Free Hospitals, United Kingdom

  • Stanford University, United States

Locations

  • New Zealand

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic Neuroendocrine Tumors

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final